ARTICLE | Company News
Ergo metabolic news
April 9, 2001 7:00 AM UTC
ERGO said it plans to sell or license its therapeutic assets, including its Ergoset bromocriptine to treat Type II diabetes. In 1999, ERGO received a letter from the FDA stating that its NDA for Ergo...